-
PASG Dashboard
- Financials
- Filings
-
Holdings
- Transcripts
- ETFs
- Insider
- Institutional
- Shorts
Passage Bio (PASG)
Company Profile
Quarter (USD) | Sep 24 | Jun 24 | Mar 24 | Dec 23 | |
---|---|---|---|---|---|
Revenue | |||||
Cost of revenue | |||||
Operating income | |||||
Operating margin | |||||
Net income | |||||
Net profit margin | |||||
Cash on hand | |||||
Change in cash | |||||
Diluted EPS |
Annual (USD) | Dec 23 | Dec 22 | Dec 21 | Dec 20 | |
---|---|---|---|---|---|
Revenue | |||||
Cost of revenue | |||||
Operating income | |||||
Operating margin | |||||
Net income | |||||
Net profit margin | |||||
Cash on hand | |||||
Change in cash | |||||
Diluted EPS |
Cash burn rate (est.) | Burn method: Change in cash | Burn method: Operating income | Burn method: FCF (opex + capex) | Last Q | Avg 4Q | Last Q | Avg 4Q | Last Q | Avg 4Q |
---|---|---|---|---|---|---|
Cash on hand (at last report) | 32.29 mm | 32.29 mm | 32.29 mm | 32.29 mm | 32.29 mm | 32.29 mm |
Cash burn (monthly) | (no burn) | 107.25 k | 6.90 mm | 6.21 mm | 2.48 mm | 4.92 mm |
Cash used (since last report) | n/a | 432.24 k | 27.81 mm | 25.05 mm | 10.00 mm | 19.82 mm |
Cash remaining | n/a | 31.86 mm | 4.48 mm | 7.25 mm | 22.29 mm | 12.47 mm |
Runway (months of cash) | n/a | 297.1 | 0.6 | 1.2 | 9.0 | 2.5 |
13F holders | Current |
---|---|
Total holders | 50 |
Opened positions | 35 |
Closed positions | 5 |
Increased positions | 3 |
Reduced positions | 0 |
13F shares | Current |
---|---|
Total value | 26.52 bn |
Total shares | 50.01 mm |
Total puts | 0.00 |
Total calls | 7.70 k |
Total put/call ratio | – |
Largest owners | Shares | Value |
---|---|---|
Orbimed Advisors | 9.82 mm | $6.88 bn |
Lynx1 Capital Management | 8.43 mm | $5.90 bn |
Vestal Point Capital | 6.10 mm | $4.27 bn |
Access Industries | 2.62 mm | $16.62 mm |
Frazier Life Sciences IX | 2.54 mm | $2.38 mm |
New Leaf Ventures III | 2.50 mm | $63.87 mm |
New Leaf Venture Partners, L.L.C. | 2.50 mm | $1.75 bn |
Erste Asset Management GmbH | 2.46 mm | $1.72 bn |
LAV Prescience | 2.20 mm | $13.97 mm |
Vanguard | 2.07 mm | $1.45 bn |
Date | Owner | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
---|---|---|---|---|---|---|---|---|---|---|
14 Jan 25 | Orbimed Advisors | Common Stock | Sell | Dispose S | Yes | No | 0.6 | 79,024 | 47.41 k | 7,034,626 |
13 Jan 25 | Orbimed Advisors | Common Stock | Sell | Dispose S | Yes | No | 0.64 | 17,986 | 11.51 k | 7,113,650 |
10 Jan 25 | Orbimed Advisors | Common Stock | Sell | Dispose S | Yes | No | 0.66 | 126,209 | 83.30 k | 7,131,636 |
8 Jan 25 | Orbimed Advisors | Common Stock | Sell | Dispose S | Yes | No | 0.68 | 75,007 | 51.00 k | 7,257,845 |
7 Jan 25 | Orbimed Advisors | Common Stock | Sell | Dispose S | Yes | No | 0.71 | 52,536 | 37.30 k | 7,332,852 |
6 Jan 25 | Orbimed Advisors | Common Stock | Sell | Dispose S | Yes | No | 0.77 | 19,481 | 15.00 k | 7,385,388 |
27 Dec 24 | Lynx1 Capital Management | Common stock, $0.0001 par value per share | Buy | Acquire P | Yes | No | 0.6451 | 373,645 | 241.04 k | 9,256,953 |
20 Dec 24 | Orbimed Advisors | Common Stock | Sell | Dispose S | Yes | No | 0.6 | 230,321 | 138.19 k | 7,404,869 |
11 Dec 24 | Orbimed Advisors | Common Stock | Sell | Dispose S | Yes | No | 0.8 | 80 | 64.00 | 7,635,190 |
10 Dec 24 | Orbimed Advisors | Common Stock | Sell | Dispose S | Yes | No | 0.8 | 8,015 | 6.41 k | 7,635,270 |